Cancer Control Program

For 30 years, the Cancer Control Program under Dr. Morrow’s leadership has conducted translational and cancer care delivery research locally and nationally investigating the prevention and management of side effects from cancer and its treatments. The seven funded faculty members are internationally known for their outstanding contributions to the field of supportive care and survivorship, for training new researchers and for being highly collaborative colleagues. They are supported by a combined total of over $35,000,000 in current extramural NIH grant funding, which includes Dr. Morrow’s $18 million dollar grant to fund clinical trial infrastructure as a Research Base for the NCI Community Oncology Research Program (NCORP).

Useful links for more information on our Cancer Control program:

• URCC NCORP
• NCORP
• Peak-Lab

Who We Are

Gary R. Morrow, Ph.D., M.S.
Director of Cancer Control

Matthew Asare, Ph.D.
Research Assistant Professor

Calvin Cole, Ph.D.
Research Assistant Professor

Eva Culakova, Ph.D.
Research Assistant Professor

Joseph Guido, M.S.
Research Senior Associate

Julia Inglis, Ph.D.
Research Assistant Professor

Nikesha J. Haynes-Gilmore, Ph.D.
Research Assistant Professor

Chuck Heckler, Ph.D., M.S.
Research Assistant Professor

Michelle Janelsins, Ph.D.
Assistant Professor

Charles Kamen, Ph.D.
Assistant Professor

Ian Robert Kleckner, Ph.D.
Research Assistant Professor

Gilberto Lopez, Sc.D., M.P.H.
Research Assistant Professor

Karen Mustian, Ph.D., M.P.H.
Associate Professor

Luke Peppone, Ph.D.
Assistant Professor

Joseph Roscoe, Ph.D.
Research Associate Professor

Supriya Mohile, M.D., M.S.
Associate Professor